Novo Nordisk to Cut 9,000 Jobs in Major Restructuring
Novo Nordisk, the global leader in diabetes and obesity treatments, has announced a sweeping restructuring plan that will result in the elimination of 9,000 jobs worldwide. This move is seen as one of the company’s most significant transformations in recent years as it navigates the growing demands of its core business while preparing for the future of healthcare innovation.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
